跳至主要内容

Factors Affecting Pharmacokinetics of Drugs


There are four factors that will influence the pharmacokinetic drugs test: water-solubility; fat-soluble; dissociation degree and molecular weight.
Pharmacokinetic is a quantitative study of drugs in the body absorption, distribution, metabolism and excretion of the law.  The use of mathematical principles and methods to explain the plasma concentration with time changes in a discipline.
Water is the carrier of drug transport and the body of the medium. Drugs in the absorption site must have a certain degree of water solubility in a dissolved state, so that can be absorbed. Therefore, the drug is required to have certain water solubility. Polarity (the introduction of polar groups can increase water solubility), crystal form (the impact of drug bioavailability is more and more attention), the melting point of the solubility, thus affecting the absorption of drugs, affecting bioavailability.
Cell membrane of the double lipid layer structure requires a certain lipid-soluble drugs can penetrate the cell membrane. Come in (some fat-soluble), get out (some water-soluble).  Dissolve easily dissociable groups such as carboxyl groups. Through the modification of chemical structure, the introduction of fat-soluble groups or side chains, can improve the drug fat-soluble, promote drug absorption and improve bioavailability.
Factors Affecting Pharmacokinetics of Drugs
Drugs can only pass through biofilm in molecular form. Biofilm itself with a charge, phase suction, into the come, get out; reprimand: not come. Ions with hydration, the drug molecule volume increases, cannot pass through the biofilm microspores. The greater the dissociation is, the worse the absorption.
The degree of dissociation is related to the dissociation constant of the drug and the pH of the absorption site. The dissociation degree of the same drug in different parts is different and the degree of absorption is different. Weak acid drug dissociation in the stomach is small, easy to be absorbed; in the intestine, weak alkaline drug dissociation is small, so it is the weak alkaline drug absorption site.
Strong acid and alkali drugs and ionic drugs are difficult to absorb, as well as difficult to come out after entering the cell.
Excretion is the process of drug excreted from the body. The kidneys are the main organs of drug excretion. Protracted by the kidneys excreted drugs in the renal tubules can be reabsorption, so that the role of drug extension. Re-absorption by the urine pH effect, the application of acidic or alkaline drugs, changes the pH of the urine, can reduce renal tubular reabsorption of drugs.
Medicilon’s pharmacokinetics department offers the clients a broad spectrum of high quality of services in the areas of in vitro ADME. With SPF animal laboratory, Medicilon can provide you, such as mice, rats, rabbits and other different species of animal pharmacokinetics experiments and the route of administration and the way is also a variety of intravenous, gavage, subcutaneous and abdominal wait.

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...